Stock listing
OTC:PHGUF Pharming Group NV Stock
US listing (OTC) of Pharming Group NV · home listing Euronext:PHARM
Follow Pharming Group NV into a list and get an email when it puts out news.
Share price · OTC:PHGUF
$1.26 USD 0.00 (0.0%)
Close on Nov 6, 2026
- Day range
- $1.26 – $1.26 USDNov 6, 2026
- Market cap
- $891.8M USDAt the close on Nov 6, 2026 · price × 707.8M shares outstanding
- 52-week range
- $0.929 – $2.17 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $198 USDMedian day 0 shares · 56 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:PHARM · Home | €1.117 EUR | -0.004 (-0.4%) | 4,519,835 | €1.12 | €1.134 | €1.113 | €1.122 | Close on Nov 18, 2026 |
| NASDAQ:PHAR | $12.06 USD | -0.53 (-4.2%) | 8,319 | $12.26 | $12.35 | $12.06 | $12.59 | Close on Nov 17, 2026 |
| OTC:PHGUF | $1.26 USD | 0.00 (0.0%) | — | $1.26 | $1.26 | $1.26 | $1.26 | Close on Nov 6, 2026 |
| Frankfurt:PHG | €10.90 EUR | -0.30 (-2.7%) | — | €10.90 | €11.10 | €10.90 | €11.20 | Close on Nov 17, 2026 |
| Stuttgart:PHGN | €1.068 EUR | -0.038 (-3.4%) | 2,437 | €1.103 | €1.132 | €1.068 | €1.106 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:PHGUF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.26 | 0.00 | 0.0% | $1.26 | $1.26 | $1.26 | 0 | |
| $1.26 | 0.00 | 0.0% | $1.26 | $1.26 | $1.26 | 0 | |
| $1.26 | 0.00 | 0.0% | $1.26 | $1.26 | $1.26 | 0 | |
| $1.26 | 0.00 | 0.0% | $1.26 | $1.26 | $1.26 | 0 | |
| $1.26 | +0.305 | +31.9% | $1.26 | $1.26 | $1.26 | 1,000 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | 0.00 | 0.0% | $0.955 | $0.955 | $0.955 | 0 | |
| $0.955 | +0.026 | +2.8% | $0.955 | $0.955 | $0.955 | 1,000 | |
| $0.929 | 0.00 | 0.0% | $0.929 | $0.929 | $0.929 | 0 | |
| $0.929 | 0.00 | 0.0% | $0.929 | $0.929 | $0.929 | 0 | |
| $0.929 | 0.00 | 0.0% | $0.929 | $0.929 | $0.929 | 0 | |
| $0.929 | -0.176 | -15.9% | $0.964 | $0.964 | $0.929 | 1,600 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 500 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 500 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 500 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | 0.00 | 0.0% | $1.105 | $1.105 | $1.105 | 0 | |
| $1.105 | +0.005 | +0.5% | $1.105 | $1.105 | $1.105 | 1,000 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 500 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 500 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | 0.00 | 0.0% | $1.10 | $1.10 | $1.10 | 0 | |
| $1.10 | -0.20 | -15.4% | $1.10 | $1.10 | $1.10 | 5,000 | |
| $1.30 | 0.00 | 0.0% | $1.30 | $1.30 | $1.30 | 0 | |
| $1.30 | 0.00 | 0.0% | $1.30 | $1.30 | $1.30 | 0 | |
| $1.30 | 0.00 | 0.0% | $1.30 | $1.30 | $1.30 | 0 | |
| $1.30 | 0.00 | 0.0% | $1.30 | $1.30 | $1.30 | 0 | |
| $1.30 | 0.00 | 0.0% | $1.30 | $1.30 | $1.30 | 0 |
Splits
1 split · OTC:PHGUF · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-10 | Consolidation |
- Ticker
- OTC:PHGUF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Latest earnings call · Jul 30, 2026
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Replay and transcript
Latest deck · November 2026
Investor Presentation (November 2026)
Investor deck · 40 slides
Calls
Replays
Pharming Group (Euronext:PHARM) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q1 2026 Earnings Call
Thu, May 07, 2026 · 7:30 AM ET
Watch TranscriptPharming Group (Euronext:PHARM) Q4 2025 Earnings Call
Thu, Mar 12, 2026 · 8:30 AM ET
Watch Transcript
Latest news
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
Nov 6, 2026
Closed $1.26 (0.0%) on Nov 6, 2026
Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
Oct 27, 2026
Closed $0.955 (0.0%) on Oct 27, 2026
Pharming Group announces third quarter 2026 revenues above market expectations
Oct 22, 2026
Closed $0.955 (0.0%) on Oct 22, 2026
Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026
Oct 14, 2026
Closed $0.929 (0.0%) on Oct 14, 2026
Pharming announces CEO transition
Sep 29, 2026
Closed $1.11 (0.0%) on Sep 29, 2026
Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS
Sep 25, 2026
Closed $1.11 (0.0%) on Sep 25, 2026
Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026
Sep 22, 2026
Closed $1.11 (0.0%) on Sep 22, 2026
FDA approves Pharming's Joenja(R) as first treatment for children with APDS in the U.S.
Sep 14, 2026
Closed $1.11 (0.0%) on Sep 14, 2026
FDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.
Sep 11, 2026
Closed $1.11 (0.0%) on Sep 11, 2026
Pharming Group to participate in September investor conferences
Sep 9, 2026
Closed $1.11 (+0.5%) on Sep 9, 2026
Decks
Investor Presentation (November 2026)
Investor deck · 40 slides · November 2026
Q3 2026 Earnings Presentation
Earnings · 32 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 41 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026
Pharming Group NV on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 34 in the last 12 months · 55 in all · newest Nov 6, 2026 · oldest 2025
- Calls
- 13 calls with a replay · 13 with a transcript · latest Jul 30, 2026
- Decks
- 85 decks · latest November 2026
Where Pharming Group NV is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:PHARM · Home listing | Euronext | Netherlands | EUR |
| NASDAQ:PHAR | NASDAQ | United States | USD |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| LSIN:0QCO | LSIN | United Kingdom | EUR |
| gettex:PHGN | gettex | Germany | EUR |
| Aquis:PHARMA | Aquis | United Kingdom | EUR |
| Tradegate:PHGN | Tradegate | Germany | EUR |
| Xetra:PHGN | Xetra | Germany | EUR |
| LS Exchange:A1H65A | LS Exchange | Germany | EUR |
| OTC:PHGUF · This page | OTC | United States | USD |
| BOATS:PHAR | BOATS | United States | USD |
| Turquoise:PHARMA | Turquoise | United Kingdom | EUR |
| gettex:PHG | gettex | Germany | EUR |
| Lang & Schwarz:A1H65A | Lang & Schwarz | Germany | EUR |
| Frankfurt:PHGN | Frankfurt | Germany | EUR |
| Hamburg:PHGN | Hamburg | Germany | EUR |
| Stuttgart:PHG | Stuttgart | Germany | EUR |
| BX Swiss:PHGN | BX Swiss | Switzerland | CHF |
| Dusseldorf:PHGN | Dusseldorf | Germany | EUR |
| Frankfurt:PHG | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2QLQY | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2QLQY | LS Exchange | Germany | EUR |
| Munich:PHGN | Munich | Germany | EUR |
| Dusseldorf:PHG | Dusseldorf | Germany | EUR |
| Munich:PHG | Munich | Germany | EUR |
| Stuttgart:PHGN | Stuttgart | Germany | EUR |
| Hanover:PHGN | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Pharming Group NV.